Ketamine's rapid antidepressant effects are mediated by adult-born immature granule neurons (ABINs) in the mouse hippocampus. Ketamine activates ABINs, and chemogenetic inhibition of ABINs blocks ketamine's antidepressant effects. Conversely, chemogenetic ABIN activation mimics ketamine's cellular and behavioral effects. This identifies ABINs as a potential therapeutic target for depression.
Publisher
Nature Communications
Published On
Nov 16, 2022
Authors
Radhika Rawat, Elif Tunc-Ozcan, Tammy L. McGuire, Chian-Yu Peng, John A. Kessler
Tags
Ketamine
depression
ABINs
hippocampus
antidepressant effects
chemogenetic activation
mice
Related Publications
Explore these studies to deepen your understanding of the subject.